Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,027 | -53,879 | -28,544 | -89,024 | -65,844 |
| Depreciation Amortization | -65 | 183 | 29 | 741 | -315 |
| Accounts payable and accrued liabilities | -11 | 1,009 | 220 | 810 | 487 |
| Other Working Capital | -2,340 | -2,183 | -2,496 | -4,541 | -4,031 |
| Other Operating Activity | 21,980 | 13,686 | 6,664 | 18,822 | 13,714 |
| Operating Cash Flow | $-54,463 | $-41,184 | $-24,127 | $-73,192 | $-55,989 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -186,062 | -182,003 | 1,447 | -36,826 | -37,553 |
| PPE Investments | -158 | -159 | -20 | -44 | -44 |
| Other Investing Activity | 0 | 0 | 0 | 873 | 873 |
| Investing Cash Flow | $-186,220 | $-182,162 | $1,427 | $-35,997 | $-36,724 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 218,363 | 218,612 | 234 | 93,977 | 93,193 |
| Other Financing Activity | -119 | 0 | 0 | 39,188 | 0 |
| Financing Cash Flow | $218,244 | $218,612 | $234 | $133,165 | $93,193 |
| Beginning Cash Position | 124,171 | 124,171 | 124,171 | 100,195 | 100,195 |
| End Cash Position | 101,732 | 119,437 | 101,705 | 124,171 | 100,675 |
| Net Cash Flow | $-22,439 | $-4,734 | $-22,466 | $23,976 | $480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,463 | -41,184 | -24,127 | -73,192 | -55,989 |
| Capital Expenditure | -158 | -159 | -20 | -44 | -44 |
| Free Cash Flow | -54,621 | -41,343 | -24,147 | -73,236 | -56,033 |